Biofrontera (BFRI) Other Operating Expenses (2020 - 2025)

Biofrontera's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $3.2 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 135.9% year-over-year to $3.2 million; the TTM figure through Dec 2025 stood at $24.2 million (up 78.72% YoY), while the FY2025 annual figure was $11.6 million, down 37.89% from the prior year.
• Other Operating Expenses was $3.2 million for Q4 2025 at Biofrontera, down from $6.9 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $13.4 million in Q3 2023 to a low of -$9.0 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $4.0 million across 5 years, with a median of $4.0 million in 2021.
• Biggest YoY gain for Other Operating Expenses was 6741.33% in 2023; the steepest drop was 168.13% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $1.8 million in 2021, then jumped by 206.86% to $5.7 million in 2022, then plunged by 168.13% to -$3.9 million in 2023, then sank by 132.78% to -$9.0 million in 2024, then jumped by 135.9% to $3.2 million in 2025.
• The last three Other Operating Expenses figures came in at $3.2 million (Q4 2025), $6.9 million (Q3 2025), and $6.8 million (Q2 2025), per Business Quant data.